{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:28:36Z","timestamp":1792517316198,"version":"4.5.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Autoinflammatory phospholipase C\u03b32 (PLC\u03b32)-associated antibody deficiency and immune dysregulation (APLAID) is a rare autoinflammatory disease caused by gain-of-function mutations in the <jats:italic>PLCG2<\/jats:italic> gene. Here we report a rare case of APLAID patient carrying a novel heterozygous missense <jats:italic>PLCG2<\/jats:italic> I169V mutation with gangrenous pyoderma and concomitant high serum immunoglobulin (Ig) E level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The patient was diagnosed as APLAID and has been treated in our department. His phenotype and genotype were carefully documented and studied. We also conducted a comprehensive literature review on APLAID.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A 23-year-old Chinese Han man presented with recurrent fever for 18 years and vesiculopustular rashes for 9 years, along with chronic bronchitis, leukocytosis, increased C-reactive protein, immunodeficiency and high serum IgE. Skin biopsy showed chronic inflammatory cells infiltration. A paternal heterozygous missense variant in exon 6 of the <jats:italic>PLCG2<\/jats:italic> gene p. I169V was identified. His vesiculopustular and IgE level responded to medium dose corticosteroids. After withdrawal of steroids, he developed severe arthritis and a large deteriorating ulceration resembling pyoderma gangrenosum on the left knee. Large dose corticosteroids were suboptimal. Then he received adalimumab with satisfactory response for arthritis and skin lesion. But he got an immunodeficiency-associated lymphoproliferative disorder 2 months later. Through literature review, there were a total of 10 APLAID patients reported by six English-language publications. Vesiculopustular rashes, sinopulmonary infection and immunodeficiency were the most frequent symptoms of APLAID patients. Glucocorticoids, intravenous immunoglobulin and biologics were clinically used to treat APLAID but none of these patients had a complete recovery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The rarity and diversity of APLAID make it difficult to be diagnosed. Our study reported the first case of APLAID with gangrenous pyoderma and concomitant high IgE carrying a novel <jats:italic>PLCG2<\/jats:italic> mutation, which may expand the clinical phenotype and genotype of APLAID.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.667430","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T05:29:59Z","timestamp":1621402199000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Case Report: A Rare Case of Autoinflammatory Phospholipase C\u03b32 (PLC\u03b32)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review"],"prefix":"10.3389","volume":"12","author":[{"given":"Na","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102421","article-title":"Systemic Autoinflammatory Diseases","volume":"109","author":"Krainer","year":"2020","journal-title":"J Autoimmun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)80721-7","article-title":"Germline Mutations in the Extracellular Domains of the 55 Kda TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3777","article-title":"The Monogenic Autoinflammatory Diseases Define New Pathways in Human Innate Immunity and Inflammation","volume":"18","author":"Manthiram","year":"2017","journal-title":"Nat Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-440x(97)80122-4","article-title":"Protein Kinase C and Phospholipase C: Bilayer Interactions and Regulation","volume":"7","author":"Hurley","year":"1997","journal-title":"Curr Opin Struct Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0898-6568(01)00252-2","article-title":"Regulation of Phospholipase C-Gamma 2 Via Phosphatidylinositol 3-Kinase in Macrophages","volume":"14","author":"Hiller","year":"2002","journal-title":"Cell Signal"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.019265","article-title":"Characterization of Phospholipase C Gamma Enzymes With Gain-of-Function Mutations","volume":"284","author":"Everett","year":"2009","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2012.08.006","article-title":"A Hypermorphic Missense Mutation in PLCG2, Encoding Phospholipase Cc2, Causes a Dominantly Inherited Autoinflammatory Disease With Immunodeficiency","volume":"91","author":"Zhou","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00731-3","article-title":"A Germline Mutation in the C2 Domain of Plc\u03b32 Associated With Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases","volume":"40","author":"Novice","year":"2020","journal-title":"J Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2020.01.008","article-title":"A New Report of Autoinflammation and PLCG2-Associated Antibody Deficiency and Immune Dysregulation (APLAID) With a Homozygous Pattern From Iran","volume":"221","author":"Khabbazi","year":"2020","journal-title":"Immunol Lett"},{"key":"B10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s10875-020-00794-7","article-title":"Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations","volume":"40","author":"Mart\u00edn-Nalda","year":"2020","journal-title":"J Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02863","article-title":"Novel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa","volume":"9","author":"Neves","year":"2018","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15918","article-title":"Expanding the Clinical Features of Autoinflammation and Phospholipase C\u03b32-Associated Antibody Deficiency and Immune Dysregulation by Description of a Novel Patient","volume":"33","author":"Mor\u00e1n-Villase\u00f1or","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2018.09.002","article-title":"Penetrance and Expressivity in Inherited Cancer Predisposing Syndromes","volume":"4","author":"Taeubner","year":"2018","journal-title":"Trends Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.38961","article-title":"Connecting Two Pathways Through Ca2+ Signaling: NLRP3 Inflammasome Activation Induced by a Hypermorphic PLCG2 Mutation","volume":"67","author":"Chae","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13972","article-title":"PLAID Syndrome: Characteristic Presentation and a Novel Therapeutic Option","volume":"37","author":"Shea","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-015-0177-x","article-title":"PLAID: A Syndrome of Complex Patterns of Disease and Unique Phenotypes","volume":"35","author":"Milner","year":"2015","journal-title":"J Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/ddg.13173","article-title":"Treatment Options for Pyoderma Gangrenosum","volume":"15","author":"Quist","year":"2017","journal-title":"J Dtsch Dermatol Ges"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.13067","article-title":"Pyoderma Gangrenosum and Tumor Necrosis Factor Alpha Inhibitors: A Semi-Systemic Review","volume":"16","author":"Abdallah","year":"2019","journal-title":"Int Wound J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.667430\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T05:30:01Z","timestamp":1621402201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.667430\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":19,"alternative-id":["10.3389\/fimmu.2021.667430"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.667430","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"article-number":"667430"}}